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Introduction
Endogenous opioids, released within the central nervous system and from the adrenohypophyseal axis, inhibit pain during stress. 24, 39 This stress-induced analgesia may have evolved to increase the likelihood of survival during times of physical threat, thereby facilitating self-defense and avoidance of further injury. 1, 38 In rodents, stressful procedures such as electric shocks and cold-water swims can evoke central opioid-mediated analgesia. 34, 35 In humans, the opiate receptor antagonist naloxone has been shown to block analgesia following cognitive stress, 3 anticipation of painful foot shock, [41] [42] [43] and the immersion of one foot in ice-water. 20 Naloxone also augmented thermal hyperalgesia induced by the topical application of capsaicin. 2 Although such findings indicate that endogenous opioids contribute to analgesia, the site of action is uncertain because the dose of naloxone used in these studies was sufficient to produce substantial blockade of opiate receptors both within and outside the central nervous system.
A component of endogenous opioid analgesia may be mediated peripherally. In rats, the withdrawal threshold to pressure applied to an inflamed paw increased after an ice-water swim, due to local release of β-endorphin from immune cells. 26, 27, 31 In humans, synovial fluid obtained during knee surgery contained immune cells, many holding β-endorphin.
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The intraarticular injection of naloxone immediately following knee surgery increased pain ratings, scores on the McGill pain questionnaire and consumption of analgesics, 33 consistent with peripheral opioid analgesia.
We recently found evidence of peripheral opioid analgesia in an experimental burn model in humans. 29 In this model, naloxone (80 µg) was injected subcutaneously at a site of mild burn injury in the forearm of 24 volunteers, and saline was injected at another burn site in the other forearm. The naloxone pre-treatment blocked the local antihyperalgesic effect of 10 µg fentanyl but did not block the antihyperalgesic effect of fentanyl injected contralaterally, -4 -consistent with local opioid receptor blockade.
The primary aim of the present study was to investigate the effect of repeatedly immersing one hand in cold water on heat-pain sensitivity at sites of burn injury (intended to evoke an inflammatory response that facilitated peripheral opioid analgesia) and elsewhere in both hands. Analgesia develops following the repeated immersion of the hand in cold water, 37 but the mechanism of this analgesia is unknown. The pain and distress evoked by the coldwater immersions might activate opioid-sensitive pain modulation processes in the central nervous system. 3, 20, 34, 35, [41] [42] [43] In addition, cold-water immersions could accelerate the local release of endogenous opioids from immune cells. [26] [27] [28] [30] [31] [32] [33] If so, this should reduce sensitivity to noxious stimulation in the immersed hand relative to the contralateral hand. Moreover, a higher concentration of immune cells at the site of burn injury might augment local opioid analgesia. To investigate this possibility, 80 µg naloxone or saline was injected subcutaneously at the burn-injured site in the immersed hand.
A second aim was to investigate effects of opioid blockade on pain tolerance during the cold water immersions. Naloxone augments shock-induced pain and cortical evoked potentials in pain-insensitive individuals, but reduces pain and evoked potentials in painsensitive people. 6 Thus, we expected that the hyperalgesic effects of opioid blockade would be greatest in pain-tolerant participants.
Method Participants
The sample consisted of 17 men and 15 women aged between 17 and 39 years (median age 19 years). They were informed that the experiment aimed to investigate the effect of the opiate antagonist naloxone on pain sensitivity induced by a mild burn and repeated immersion of their hand in cold water. Each participant received A$20 for time spent and provided informed consent for the procedures, which were approved by the Ethics Committee of the University of Western Australia.
Apparatus and Procedures
The sequence of procedures is summarized in Table 1 . Participants attended the laboratory on two occasions, separated by 4 to 7 days. The temperature of the laboratory ranged between 20 and 23ºC. On each occasion, the 10-mm diameter probe of a thermocouple-controlled cautery unit, heated to 48 o C, was applied with a force of approximately 1 N in hairy skin over the first dorsal interosseous muscle of each hand for 120 s to produce a mild burn.
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Thirty minutes later, heat-pain thresholds (HPT) were measured at the burn site and at a control site 2-5 cm laterally from each burn site on both hands. Although the burn sites were approximately the same on each occasion, the HPT after the burn did not differ systematically from the first to the second occasion, irrespective of whether naloxone or saline was injected at the site of burn injury on the first occasion. Thus, effects of the burn and injection on the HPT appeared to have dissipated by the second occasion.
The HPT was determined by directing radiant heat from a halogen globe through a lens and circular aperture (1.1 cm in diameter) onto the skin. Skin temperature was measured by a thermistor which was positioned under an aluminum shield in the centre of the aperture. The arm of the lamp was adjusted to allow the thermistor to touch the skin lightly without transferring the weight of the lamp. Skin temperature was held at a baseline of 35.6ºC for 10 s and then increased linearly at 0.5ºC per second. Participants switched the heat lamp off when they first felt pain (the HPT) or the heat lamp was automatically switched off when the temperature reached 47 o C. Two HPT estimates were conducted at each site, with a third administered if the first two differed by more than 2ºC. Participants wore an eye-mask during sensory testing to minimize visual cues that might otherwise have affected the HPT.
After the post-burn assessment, 0.2 mL 0.9% saline, with or without 80 g naloxone hydrochloride, was injected subcutaneously into one of the burn sites (the dominant hand on 50% of occasions). The injection was administered double-blind, and half the participants received naloxone in the first session. The HPT was measured again starting five minutes after the injection.
Skin temperature was then measured with an insulated thermistor at the four test sites, and participants began a series of immersions of the hand that had been injected with naloxone or saline. On each trial, participants immersed their hand up to the wrist in stirred 2 o C water for as long as they could or until three minutes had elapsed. The immersion duration at pain onset and the total immersion duration (the immersion pain tolerance) were recorded for each trial. Upon removal of the hand, participants gave a verbal rating of the maximum pain experienced during the immersion, ranging from 0 (no pain) to 10 (worst pain ever). The hand remained out of the water for 20 s and was then re-immersed. Each participant completed six to ten trials. Trials were discontinued when one of the following criteria 37 was met: (1) at least six trials were completed and cumulative immersion time across the trials was at least 10 minutes; (2) at least six trials were completed and immersion time was three minutes on three consecutive trials; or (3) ten trials were completed.
Upon completion of the cold-water immersions, the immersed hand was placed in warm water at 33 + 1ºC for 1-2 minutes and was held in front of a fan heater at the maximum comfortable temperature for a further 2-3 minutes. The cold-induced pain subsided rapidly during re-warming. Warming was discontinued when skin temperature approximated preimmersion levels. The HPT was then re-measured two more times, with a 5-minute interval between the first and the second measure.
Data are displayed as means (M) + standard error of the mean. Experimental effects were investigated in repeated measures analyses of variance and with Pearson's correlation coefficient (r). The multivariate solution was employed for repeated measures factors with more than two levels.
RESULTS

Changes in skin temperature
Mean skin temperature was greater at the burnt sites than the unburnt sites ( (Table 2) . Thus, the inflammatory response at the burn sites increased skin temperature, and warming the hand after the immersions returned skin temperature to pre-immersion levels.
Effect of naloxone on pain during the immersions
As opioid release during the immersions might influence pain sensitivity, we examined the effect of the opioid antagonist naloxone on pain during the immersions. The average duration of immersion correlated strongly across sessions, r (30) = .69, p < .001 ( Figure 1A) but, nevertheless, was shorter in the naloxone session than the saline session in the most pain- These findings suggest that opioid release was greatest in pain-tolerant participants during the cold-water immersions. Thus, changes in sensitivity to heat after the immersions were explored in relation to individual differences in cold pain tolerance in analyses of variance. The results of these analyses are presented below.
Effect of the injections and the immersions on the HPT
Preliminary analyses indicated that the HPT was lower at the burnt sites than the unburnt However, in the mid-range group, naloxone evoked thermal hypoalgesia at unburnt sites in both hands ( Figure 4B ). In pain-intolerant participants, naloxone blocked thermal hypoalgesia after the immersions only at an unburnt site in the immersed hand ( Figure 4C ).
DISCUSSION
The effect of the immersions on the HPT
The primary aim of this study was to determine whether subcutaneous injection of naloxone at a site of burn injury in the hand would modify thermal hyperalgesia locally after the hand was immersed repeatedly in painfully cold water. Sensitivity to heat decreased at the burnt site in the immersed hand after the immersions, but was unaffected by opioid receptor blockade.
The mechanism of this reduction in sensitivity to heat is uncertain. To minimize the possibility that cold-induced nerve conduction block would influence sensitivity to heat after the immersions, the hand was re-warmed to pre-immersion temperatures before measuring the HPT. Myelinated fibres appear to be more susceptible to cold-induced conduction block than non-myelinated fibres. 15 Washington et al. 37 reported that conduction velocity along myelinated fibres was unaltered after the hand was re-warmed following repeated cold-water immersions. Given that non-myelinated fibres contribute to heat-pain perception in humans, 17, 40 an effect of cold-induced conduction block on the HPT after the hand was rewarmed seems unlikely. Moreover, the progressive decrease in sensitivity to heat in the immersed hand after the immersions is not consistent with a cold-induced nerve conduction block, which should dissipate rather than intensify over time.
Nevertheless, a local effect of the immersions appeared to contribute to hypoalgesia, because it developed sooner at the burn site in the immersed hand than in the non-immersed hand. Indeed, sensitivity to heat increased transiently after the immersions in the nonimmersed hand. This finding was unexpected, because processes such as diffuse noxious inhibitory controls generally suppress painful sensations after intense noxious stimulation.
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The mechanism of contralateral hyperalgesia after the immersions requires further investigation.
Individual differences in tolerance of cold-pain
Willingness to tolerate cold-evoked pain varied greatly within our sample of healthy young adults. This variation was unrelated to age, sex, or heat-pain thresholds before the immersions. Geisser and colleagues 16 found that pain-intolerant individuals reported more unhelpful coping strategies (catastrophizing, praying, and hoping), and fewer helpful coping strategies (coping self-statements and ignoring the pain) than pain-tolerant participants. In addition, pain-intolerant individuals considered that they had less control over pain and their ability to reduce it than pain-tolerant individuals. Similarly, Chen et al. 8 reported that anxiety and general fearfulness were associated with pain intensity ratings in pain-intolerant but not pain-tolerant participants. Although the generality of the pain tolerance dichotomy has been questioned, 21 individual differences in pain sensitivity and tolerance are associated with biological markers. 12, 18 For example, genetic variations that regulate levels of catecholamine- 12 may influence pain sensitivity and opioid activity in pain-tolerant people. In addition, activity in cerebral cortical regions that process painful sensations and that coordinate emotional responses to pain is greater in pain-sensitive than pain-insensitive individuals, 9 possibly due to inhibitory effects of opioid release in pain-insensitive people. 6 In the present study, naloxone augmented cold-induced pain in the pain-tolerant group. In particular, pain tolerance was lower and pain ratings were higher in the naloxone than saline condition during the third and fourth immersion trials, and pain began sooner in the naloxone than the saline condition in the sixth trial. Why the onset of the hyperalgesic effects of naloxone differed across the different pain measures is unclear; however, it seems reasonable to assume that noxious stimulation would trigger opioid release more readily above than below the pain threshold. If so, opioid effects on the pain threshold would, by necessity, lag behind opioid effects on pain tolerance and pain ratings. In addition, psychological factors (e.g., fear of pain or low self efficacy) that provoke opioid release -and which may then be modified by this release -might have a greater influence on pain tolerance and ratings than on pain thresholds. In any event, the findings suggest that individual differences in evoked opioid release during repeated painful stimulation contribute to individual differences in pain tolerance.
O-methytransferase
After the immersions, naloxone antagonized decreases in heat-pain sensitivity in paintolerant participants at an unburnt site in the non-immersed hand (i.e., at some distance from the site of injection, implying that naloxone had entered the systemic circulation). In animal studies, central opioid-mediated analgesia develops during prolonged stress, 10 particularly when the stress is inescapable. 5, 19 Similarly, experimentally induced stress evokes opioid analgesia in healthy humans, 3, 20, [41] [42] [43] and may have induced a similar response during lengthy immersions in the present study. Alternatively, naloxone may have acted peripherally on opioid receptors in the non-immersed hand. Why this was limited to the unburnt site in the non-immersed hand is unclear; one possibility is that hyperalgesia due to the burn injury, and/or hypoalgesia after the immersions, masked the modulatory effect of opioid release.
Naloxone produced quite different effects at the unburnt site in the non-immersed hand in participants who tolerated medium-length immersions. In particular, naloxone facilitated thermal hypoalgesia, implying that naloxone decreased or opioids increased sensitivity to noxious heat. It is interesting to note the parallels between our findings and those of Buchsbaum et al., 6 who reported that naloxone inhibited shock-induced pain in pain-sensitive individuals but enhanced shock-induced pain in pain-insensitive individuals. Low levels of opiate drugs such as morphine induce hyperalgesia; 22 thus, it is tempting to speculate that minor opioid release in the central nervous system augmented thermal hyperalgesia after medium-length immersions. Alternatively, systemic release of opioids may have indirectly sensitized peripheral nerves via inflammatory mechanisms. 13, 14, 23, 25 Naloxone also blocked a decrease in sensitivity to heat in pain-intolerant participants at the unburnt site in the immersed hand after the immersions. As this was limited to the immersed hand, this finding is consistent with local opioid analgesia. In animal studies, peripheral opioid analgesia during cold-water swims is mediated by opioid receptors on the peripheral terminals of sensory nerves which are stimulated by β-endorphin. 26, 28, 31, 32 The β-endorphin appears to be released from immune cells by corticotrophin-releasing factor, 30 interleukin-1, 7 and noradrenaline. 4 
Methodological issues
Immersion duration was controlled by the participants rather than the experimenter, and may reflect a stable individual trait that moderates sensitivity to pain. Thus, further studies that systematically vary the immersion duration are required to determine whether immersion duration or individual differences in pain tolerance affect opioid activity.
We expected that burn-induced inflammation would intensify local opioid analgesia due to an accumulation of immune cells at the site of burn injury. However, for unknown reasons, effects of naloxone were weaker at burnt than unburnt sites. One potential explanation is that local vascular or inflammatory responses during the immersions increased accessibility to peripheral opioid receptors at unburnt sites. Alternatively, the inflammatory effect of the burn might have spread to adjacent skin in the immersed hand, or the burn injury may not have been severe enough to result in local accumulation of immune cells.
Based on our previous work, 29 we expected that effects of naloxone would be greatest at the site of injection. However, the present findings suggest that naloxone acted at a distance to augment (after medium-length immersions) or block (after lengthy immersions) thermal hypoalgesia contralateral to the site of injection. Studies involving injection of naloxone in the non-immersed hand may help to further distinguish between the effects of local versus systemic or central opioid release on sensitivity to heat-pain in this experimental paradigm.
The effects of systemic and local opioid release on other nociceptive modalities (e.g., pain to pressure, cold, and punctuate stimulation) should also be explored.
Finally, investigation of the effects of naloxone in relation to cold-pain tolerance should be considered exploratory in the present study, because the sample size was small. In particular, findings in pain-intolerant subjects must be treated with caution because of the small number of participants in this group. Groups were defined post hoc at noticeable, but perhaps serendipitous, breaks in the distribution of immersion duration scores in the saline session. Cold-pain tolerance remained reasonably stable across sessions in the present study, particularly during the first immersion ( Figure 2D-F) , suggesting that cold-pain tolerance is a stable individual trait. However, the group structure identified in this study needs to be confirmed in a larger sample.
Conclusions
Cold-water immersions induced complex opioid-mediated effects on nociceptive processing. Systemic or central opioid release inhibited cold-evoked pain during lengthy immersions, and inhibited sensitivity to heat at an unburnt site in the non-immersed hand after the immersions. However, in participants who tolerated medium-length immersions, systemic or central opioid release appeared to augment sensitivity to heat after the immersions. This hyperalgesic response may have overshadowed inhibitory effects of local opioid release on sensitivity to heat, which were detected only after brief immersions. Hand re-warmed for 3-5 min to pre-immersion temperature 7.
HPT measured at both sites in both hands straight after the hand was re-warmed, and again 5 min later 8.
Procedures repeated 4-7 days later with subcutaneous injection of the agent (naloxone or saline) not administered in the first session Note: none of the differences among groups was statistically significant. 
